Government of Sweden Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4
Founded: Stockholm Sweden (1905)

Organization Overview

First Clinical Trial
2004
NCT00811239
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

ALF Swedish Government Grant | County Council of Norrbotten, Sweden | County council of Östergötland | County Councils of Region Östergötland, Kalmar and Jönköping | FORTE | Håkan Hanberger | Jämtland County Council, Sweden | Jönköping county council | Katarina Hedin | Malmo Municipality, Sweden | Ministry of Health and Social Affairs, Sweden | NU-Hospital Organization, Sweden | Public Health Agency of Sweden | Region Jönköping County | Region Östergötland, Sweden | Region Värmland, Sweden | Region Västra Götaland, Sweden | Research, Education, Development & Innovation, Primary Health Care, Region Västra Götaland, Sweden | Stockholm County Council, Sweden | Swedish Armed Forces | Swedish International Development Cooperation Agency (SIDA) | Swedish National Board of Health and Welfare | Västernorrland County Council, Sweden

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 1)

Asphyxia (Phase 3)

Asphyxia Neonatorum (Phase 3)

Attention Deficit Disorder with Hyperactivity (Phase 3)

Birth Weight (Phase 1)

Communicable Diseases (Phase 4)

Compulsive Personality Disorder (Phase 4)

Cystic Fibrosis (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Disease (Phase 1)

Dysentery, Bacillary (Phase 2)

Dysmenorrhea (Phase 2)

Endometriosis (Phase 2)

Fetal Distress (Phase 3)

Fibrosis (Phase 2)

Graft vs Host Disease (Phase 2)

Heroin Dependence (Phase 4)

HIV Infections (Phase 3)

Hyperkinesis (Phase 3)

Hypersensitivity (Phase 2)

Infections (Phase 4)

Inflammation (Phase 4)

Insulin Resistance (Phase 2)

Neoplasms (Phase 2)

Obsessive-Compulsive Disorder (Phase 4)

Opioid-Related Disorders (Phase 1)

Pharyngitis (Phase 4)

Schizophrenia (Phase 3)

Snake Bites (Phase 2)

Substance-Related Disorders (Phase 1)

Tonsillitis (Phase 4)

Urinary Tract Infections (Phase 4)

Vitamin D Deficiency (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 36
  • # of Trial APIs: 43